Jefferies Group’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Jefferies Group’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-40,000	Closed	-$432K	–	1997
2020 Q4	$432K	Sell	40,000 -60,000	-60%	-$618K	﹤0.01%	1190
2020 Q3	$1.04M	Sell	100,000 -50,593	-34%	-$526K	0.01%	788
2020 Q2	$1.51K	Buy	+150,593	New	+$1.5M	0.02%	655

Other funds holding STLN

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SRCM

Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

Jefferies Group's STLN Position: Q1 2021 in Review

Jefferies Group sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q1 2021, closing a stake of 40,000 shares — an estimated $432K sold.

Jefferies Group first reported a position in STLN in Q2 2020 and held it in 3 quarters. The position peaked at $1.04M in Q3 2020. 50 funds tracked by Wall St. Rank hold STLN as of Q1 2021.

Jefferies Group reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Jefferies Group sold 40,000 Starling Oncology Institute, Inc. Common Stock shares in Q1 2021, an estimated $432K.
Jefferies Group first reported a position in Starling Oncology Institute, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
Jefferies Group's Starling Oncology Institute, Inc. Common Stock position peaked at $1.04M in Q3 2020.
50 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2021.

Based on Jefferies Group's 13F filing for Q1 2021, filed 14 May 2021.